<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Yasheng Group — News on 6ix</title>
<link>https://6ix.com/company/yasheng-group</link>
<description>Latest news and press releases for Yasheng Group on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 10 May 2023 05:15:41 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/yasheng-group" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68357d1c78dffbe2df0fa091.webp</url>
<title>Yasheng Group</title>
<link>https://6ix.com/company/yasheng-group</link>
</image>
<item>
<title>Yasheng Group Reports Financial Results for the First Quarter of 2023</title>
<link>https://6ix.com/company/yasheng-group/news/yasheng-group-reports-financial-results-for-the-first-quarter-of-2023</link>
<guid isPermaLink="true">https://6ix.com/company/yasheng-group/news/yasheng-group-reports-financial-results-for-the-first-quarter-of-2023</guid>
<pubDate>Wed, 10 May 2023 05:15:41 GMT</pubDate>
<description>Yasheng Group Reports Financial Results for the First Quarter of 2023.</description>
</item>
<item>
<title>Rare Earth Elements Collected from Wastewater Utilizing Cyanobacteria Now Patent Pending</title>
<link>https://6ix.com/company/yasheng-group/news/rare-earth-elements-collected-from-wastewater-utilizing-cyanobacteria-now-patent-pending</link>
<guid isPermaLink="true">https://6ix.com/company/yasheng-group/news/rare-earth-elements-collected-from-wastewater-utilizing-cyanobacteria-now-patent-pending</guid>
<pubDate>Wed, 15 Mar 2023 10:00:00 GMT</pubDate>
<description>Rare Earth Elements Collected from Wastewater Utilizing Cyanobacteria Now Patent Pending.</description>
</item>
<item>
<title>Yasheng Group Notifies FINRA of Plan to Pay Preferred Dividend to Common Shareholders</title>
<link>https://6ix.com/company/yasheng-group/news/yasheng-group-notifies-finra-of-plan-to-pay-preferred-dividend-to-common-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/yasheng-group/news/yasheng-group-notifies-finra-of-plan-to-pay-preferred-dividend-to-common-shareholders</guid>
<pubDate>Wed, 01 Mar 2023 07:17:16 GMT</pubDate>
<description>Yasheng Group Notifies FINRA of Plan to Pay Preferred Dividend to Common Shareholders.</description>
</item>
<item>
<title>Yasheng's AI-Powered Cancer Therapy Patent Revolutionizes Immunotherapy Development</title>
<link>https://6ix.com/company/yasheng-group/news/yashengs-ai-powered-cancer-therapy-patent-revolutionizes-immunotherapy-development</link>
<guid isPermaLink="true">https://6ix.com/company/yasheng-group/news/yashengs-ai-powered-cancer-therapy-patent-revolutionizes-immunotherapy-development</guid>
<pubDate>Mon, 27 Feb 2023 21:08:06 GMT</pubDate>
<description>Yasheng's AI-Powered Cancer Therapy Patent Revolutionizes Immunotherapy Development.</description>
</item>
<item>
<title>Yasheng Group Resumes Plan to Pay Preferred Dividend to Common Shareholders; Raise Capital for our Subsidiary, Jove Pharmaceutics In Order to Bring Next Generation Cancer Curing Cell Therapeutics to M</title>
<link>https://6ix.com/company/yasheng-group/news/yasheng-group-resumes-plan-to-pay-preferred-dividend-to-common-shareholders-raise-capital-for-our-subsidiary-jove-pharmaceutics-in-order-to-bring-next-generation-cancer-curing-cell-therapeutics-to-m</link>
<guid isPermaLink="true">https://6ix.com/company/yasheng-group/news/yasheng-group-resumes-plan-to-pay-preferred-dividend-to-common-shareholders-raise-capital-for-our-subsidiary-jove-pharmaceutics-in-order-to-bring-next-generation-cancer-curing-cell-therapeutics-to-m</guid>
<pubDate>Fri, 20 Jan 2023 19:41:52 GMT</pubDate>
<description>Yasheng Group Resumes Plan to Pay Preferred Dividend to Common Shareholders; Raise Capital for our Subsidiary, Jove Pharmaceutics In Order to Bring Next Generation Cancer Curing Cell Therapeutics to M.</description>
</item>
<item>
<title>Yasheng Group Teams Up with Jove Pharmaceutics In Order to Bring Next Generation Cancer Curing Cell Therapeutics to Market</title>
<link>https://6ix.com/company/yasheng-group/news/yasheng-group-teams-up-with-jove-pharmaceutics-in-order-to-bring-next-generation-cancer-curing-cell-therapeutics-to-market</link>
<guid isPermaLink="true">https://6ix.com/company/yasheng-group/news/yasheng-group-teams-up-with-jove-pharmaceutics-in-order-to-bring-next-generation-cancer-curing-cell-therapeutics-to-market</guid>
<pubDate>Tue, 23 Aug 2022 10:00:00 GMT</pubDate>
<description>Yasheng Group Teams Up with Jove Pharmaceutics In Order to Bring Next Generation Cancer Curing Cell Therapeutics to Market.</description>
</item>
<item>
<title>Yasheng Group Reports Financial Results for the Second Quarter, 2022</title>
<link>https://6ix.com/company/yasheng-group/news/yasheng-group-reports-financial-results-for-the-second-quarter-2022</link>
<guid isPermaLink="true">https://6ix.com/company/yasheng-group/news/yasheng-group-reports-financial-results-for-the-second-quarter-2022</guid>
<pubDate>Tue, 02 Aug 2022 04:00:00 GMT</pubDate>
<description>Yasheng Group Reports Financial Results for the Second Quarter, 2022.</description>
</item>
<item>
<title>Yasheng Group Reports Full-Year 2021 Financial Results: Sets New Spin-Off Date; Updates on Solar and Mining Projects</title>
<link>https://6ix.com/company/yasheng-group/news/yasheng-group-reports-full-year-2021-financial-results-sets-new-spin-off-date-updates-on-solar-and-mining-projects</link>
<guid isPermaLink="true">https://6ix.com/company/yasheng-group/news/yasheng-group-reports-full-year-2021-financial-results-sets-new-spin-off-date-updates-on-solar-and-mining-projects</guid>
<pubDate>Wed, 09 Mar 2022 19:57:15 GMT</pubDate>
<description>Yasheng Group Reports Full-Year 2021 Financial Results: Sets New Spin-Off Date; Updates on Solar and Mining Projects.</description>
</item>
</channel>
</rss>